Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen
<p><strong>Purpose</strong> To conduct meta-analyses of randomized trials of aromatase inhibitors (AIs) compared with tamoxifen either as initial monotherapy (cohort 1) or after 2 to 3 years of tamoxifen (cohort 2).</p> <p><strong>Materials and Methods</strong...
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
American Society of Clinical Oncology
2009
|